Skip to main content
FDA expands use of Edwards' Sapien 3 heart valve
6/7/2017

The FDA has given Edwards Lifesciences approval for the expanded use of its Sapien 3 Transcatheter Heart Valve, a device designed to be placed in the aortic and mitral valves in patients at risk for open-heart surgery. The approval allows the device to be used in valve-in-valve procedures.

Full Story: